Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Higher doses reached that plateau later in the trial. In a 112-week step-down trial, participants maintained 21.9% loss on the top dose, 16.6% after stepping down to 5 mg, and 9.9% on placebo
Tips for the transition Learn what happens when you stop taking a GLP-1 weight-loss drug and how to sustain results
Ballas expert guidance ensures you get the best value and support throughout your weight loss journey
Gallbladder Disease: Increased risk of gallstones and cholecystitis
The pattern typically unfolds over months: tirzepatide produces weight loss and inflammation reduction, which allows a gradual steroid taper, which further improves weight and metabolic health, which may allow additional steroid reduction
US$ 25.72
US$ 23.56
US$ 29.73
US$ 29.31
